SIH Research, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Alzheimer disease1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Closed trials

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source

• Terminated

  Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT02446132· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source